Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
As of today, Johnson & Johnson(JNJ) shares are valued at $219.72. The company's market cap stands at 530.41B, with a P/E ratio of 19.95 and a dividend yield of 2.3%.
On 2026-01-25, Johnson & Johnson(JNJ) stock traded between a low of $217.84 and a high of $221.21. Shares are currently priced at $219.72, which is +0.9% above the low and -0.7% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 6.95M, against a daily average of 10.86M.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $222.17 at its peak.
During the past year, Johnson & Johnson(JNJ) stock moved between $141.50 at its lowest and $222.17 at its peak.
JNJ News
Earlier this week, Johnson & Johnson reported fourth-quarter 2025 and full-year results showing sales of US$24.56 billion for the quarter and US$94.19 billion f...
The TipRanks AI Analyst tool scans analyst ratings, price targets, and market trends to highlight stocks with strong upside potential. Using TipRanks’ AI Analys...
Social Security Faces 24% Benefit Cut in 2032 Without Congressional Action Quick Read Johnson & Johnson (JNJ) and Procter & Gamble dividend growth averaged 5%...
Analyst ratings
52%
of 23 ratingsMore JNJ News
Consolidating into Schwab US Dividend Equity ETF (SCHD) or Vanguard High Dividend Yield ETF (VYM) cuts monitoring from five positions to one. NVIDIA returned 1...
Guggenheim analyst Vamil Divan raised the firm’s price target on Johnson & Johnson to $240 from $227 and keeps a Buy rating on the shares after the company repo...
Key Points Johnson & Johnson has increased its dividend for an impressive 63 consecutive years. The company appears to be navigating an expanding patent cliff...
Johnson & Johnson's (NYSE:JNJ) shares came under pressure, despite the fourth-quarter revenue beat and in-line 2026 guidance, mainly due to stock outperformance...
Playing It Safe at 70 With $2.5 Million Is Likely To Backfire Quick Read A $2.5M portfolio in Johnson & Johnson (JNJ), Microsoft (MSFT), P&G (PG), Coca-Cola (K...
If you are wondering whether Johnson & Johnson shares still offer value at around US$218.01, you are not alone. Many investors are asking the same question as t...
Key Points Johnson & Johnson has increased its dividend each year for over half a century. The company has a very healthy financial profile. It has excellent...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset